Eurofins Scientific SE (EPA:ERF)
France · Delayed Price · Currency is EUR 66.40
+0.28 (0.42%)
Jul 24, 2026, 5:35 PM CET
Eurofins Scientific SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 726.9 | 654.1 | 554.6 | 423.3 | 780 | 1,057 |
Depreciation & Amortization | 618 | 629.5 | 596.9 | 565 | 504.4 | 450.7 |
Stock-Based Compensation | 140.4 | 138.1 | 138.3 | 137.7 | 136.1 | 131 |
Other Adjustments | 140.4 | 113.9 | 138.3 | 107.4 | -21.2 | 189.7 |
Changes in Income Taxes Payable | -174.2 | -188.8 | -160.7 | -139.7 | -296.1 | -296.7 |
Changes in Other Operating Activities | 35.2 | 52.1 | 51.4 | -75.8 | 33 | -19.9 |
Operating Cash Flow | 1,487 | 1,399 | 1,319 | 1,018 | 1,136 | 1,511 |
Operating Cash Flow Growth | 6.27% | 6.07% | 29.57% | -10.42% | -24.82% | 23.53% |
Capital Expenditures | -428.4 | -759.9 | -453.6 | -478.1 | -576.1 | -444.4 |
Sale of Property, Plant & Equipment | 21.3 | 14.2 | 10.2 | 6.4 | 14.9 | 24.8 |
Purchases of Intangible Assets | -76.5 | -74.9 | -74.8 | -72 | -84.1 | -62 |
Cash Acquisitions | -241.1 | -261.4 | -343.4 | -158.1 | -430 | -530.6 |
Proceeds from Business Divestments | -5.9 | -2.8 | -0.9 | 7.3 | 215.3 | -2 |
Other Investing Activities | 17.2 | 8.7 | 16.1 | 13.5 | 4 | -6.7 |
Investing Cash Flow | -1,015 | -1,076 | -846.5 | -681.1 | -855.9 | -1,021 |
Long-Term Debt Issued | 633.2 | 1,619 | 118 | 1,232 | 633.9 | 826.3 |
Long-Term Debt Repaid | -423.7 | -710.1 | -477.7 | -272.7 | -500.2 | -1,280 |
Net Long-Term Debt Issued (Repaid) | 209.5 | 908.7 | -359.7 | 959.3 | 133.7 | -453.7 |
Issuance of Common Stock | - | - | 0.2 | 8 | 14.6 | 35.8 |
Repurchase of Common Stock | -287 | -541.3 | -271.9 | -55.8 | -15.8 | -3.6 |
Net Common Stock Issued (Repurchased) | -287 | -541.3 | -271.7 | -47.8 | -1.2 | 32.2 |
Common Dividends Paid | -128.7 | -109.8 | -98 | -193.1 | -192.5 | -130.4 |
Other Financing Activities | -386.1 | -359.2 | -360.1 | -304.7 | -251.4 | -358.5 |
Financing Cash Flow | -592.2 | -101.6 | -1,090 | 413.6 | -311.3 | -910.3 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 4 | -46.6 | 9.4 | -12.7 | -0.8 | 24.3 |
Net Cash Flow | -116.2 | 174.6 | -607.7 | 737.8 | -31.8 | -395.5 |
Free Cash Flow | 1,058 | 639 | 865.3 | 539.8 | 560.2 | 1,067 |
Free Cash Flow Growth | 65.60% | -26.15% | 60.30% | -3.64% | -47.50% | 16.91% |
FCF Margin | 14.33% | 8.76% | 12.45% | 8.29% | 8.35% | 15.88% |
Free Cash Flow Per Share | 5.75 | 3.43 | 4.45 | 2.73 | 2.82 | 5.32 |
Levered Free Cash Flow | 789.3 | 1,116 | 80.7 | 1,141 | 409.1 | 18.6 |
Unlevered Free Cash Flow | 691.16 | 300.2 | 531.55 | 256.71 | 376.63 | 622.1 |